AbbVie staves off 6th Humira biosimilar in US

Submitted by admin on November 7, 2018 - 10:44pm

Source:

Biopharma Dive

News Tags:

Headline:

snippet:

AbbVie reached yet another deal with a rival to hold off the U.S. launch of a Humira biosimilar until 2023, the company announced Tuesday.

Search form